Status: current, Defined. Date: 30-Jun 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3397721000168113 | Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3397731000168111 | Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | Is a | hydrocortisone (as sodium succinate) 500 mg injection, chamber | true | Inferred relationship | Some | ||
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | Is a | Solu-Cortef Act-O-Vial | true | Inferred relationship | Some | ||
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | has unit of use | chamber | true | Inferred relationship | Some | 1361508404 | |
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | has intended active ingredient | hydrocortisone sodium succinate | true | Inferred relationship | Some | 1361508403 | |
| Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | has Australian BoSS | hydrocortisone | true | Inferred relationship | Some | 1361508403 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Solu-Cortef Act-O-Vial (1 x 500 mg chamber, 1 x 4 mL inert diluent chamber), 1 dual chamber vial | has TPUU | True | Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | Inferred relationship | Some | 2 |
| Solu-Cortef Act-O-Vial (1 x 500 mg chamber, 1 x 4 mL inert diluent chamber), 1 dual chamber vial | has TPUU | True | Solu-Cortef Act-O-Vial (hydrocortisone (as sodium succinate) 500 mg) powder for injection, 500 mg chamber | Inferred relationship | Some | 2 |
Reference Sets
Trade product unit of use reference set
FHIR